|
JP2008233093A
|
|
Profiling method of chemical action on living body by compound and its usage
|
|
JP2008239616A
|
|
Hdl (high density lipoprotein) enhancer
|
|
JP2007200315A
|
|
Method for predicting medical molecule side effect and method for predicting drug discovery target
|
|
JP2004051600A
|
|
Hematopoietic organ type prostaglandin d2 synthetase inhibitor
|
|
JP2001318102A
|
|
Evaluation method for interaction between biopolymer and ligand
|
|
JP2001290822A
|
|
Device giving priority to candidate gene
|
|
JP2001256320A
|
|
Authenticating method for document date
|
|
JP2001167123A
|
|
Method for managing gene arrangement multiple class
|
|
JP2001075475A
|
|
Date authenticating method
|
|
JP2001031660A
|
|
Thyroid hormone-like action substance
|
|
JP2000319203A
|
|
Formation of three dimensional structure of compound
|
|
JP2000273076A
|
|
Retinoid agonist
|
|
JP2000119255A
|
|
Protein kinase c-activation modifier
|
|
JPH11171773A
|
|
Dihydrofolic acid reductase inhibitor
|
|
JPH11171776A
|
|
Prophylactic and treating agent for diabetes
|
|
JPH10310526A
|
|
Dihydrofolic acid reductase inhibitor
|
|
JPH10287696A
|
|
Estimation of function of protein
|
|
JPH10251144A
|
|
Interleukin-6 production inhibitor
|
|
JPH10237050A
|
|
Retinoid compound
|
|
JPH10101644A
|
|
Pineal hormone agonist
|
